BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17311618)

  • 1. Yo jyo hen shi ko, a novel Chinese herbal, prevents nonalcoholic steatohepatitis in ob/ob mice fed a high fat or methionine-choline-deficient diet.
    de Lima VM; de Oliveira CP; Sawada LY; Barbeiro HV; de Mello ES; Soriano FG; Alves VA; Caldwell SH; Carrilho FJ
    Liver Int; 2007 Mar; 27(2):227-34. PubMed ID: 17311618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic steatohepatitis (NASH) in ob/ob mice treated with yo jyo hen shi ko (YHK): effects on peroxisome proliferator-activated receptors (PPARs) and microsomal triglyceride transfer protein (MTP).
    Stefano JT; de Oliveira CP; Corrêa-Giannella ML; de Lima VM; de Sá SV; de Oliveira EP; de Mello ES; Giannella-Neto D; Alves VA; Carrilho FJ
    Dig Dis Sci; 2007 Dec; 52(12):3448-54. PubMed ID: 17394061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats.
    Tahan V; Atug O; Akin H; Eren F; Tahan G; Tarcin O; Uzun H; Ozdogan O; Tarcin O; Imeryuz N; Ozguner F; Celikel C; Avsar E; Tozun N
    J Pineal Res; 2009 May; 46(4):401-7. PubMed ID: 19552763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
    Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice.
    de Oliveira CP; Stefano JT; de Lima VM; de Sá SV; Simplicio FI; de Mello ES; Corrêa-Giannella ML; Alves VA; Laurindo FR; de Oliveira MG; Giannella-Neto D; Carrilho FJ
    J Hepatol; 2006 Nov; 45(5):725-33. PubMed ID: 16935387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.
    Veteläinen R; van Vliet A; van Gulik TM
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1526-33. PubMed ID: 17716355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.
    Samuhasaneeto S; Thong-Ngam D; Kulaputana O; Patumraj S; Klaikeaw N
    J Med Assoc Thai; 2007 Apr; 90(4):788-97. PubMed ID: 17487136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
    Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
    J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
    McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
    Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teucrium polium in prevention of steatohepatitis in rats.
    Amini R; Nosrati N; Yazdanparast R; Molaei M
    Liver Int; 2009 Sep; 29(8):1216-21. PubMed ID: 19602140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chunggan extract (CGX), methionine-and choline-deficient (MCD) diet-induced hepatosteatosis and oxidative stress in C57BL/6 mice.
    Park HJ; Han JM; Kim HG; Choi MK; Lee JS; Lee HW; Son CG
    Hum Exp Toxicol; 2013 Dec; 32(12):1258-69. PubMed ID: 23970447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
    Rangnekar AS; Lammert F; Igolnikov A; Green RM
    Liver Int; 2006 Oct; 26(8):1000-5. PubMed ID: 16953841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.